These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8639734)

  • 21. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K; Altundag O; Gunduz E; Silay YS; Boruban C
    Med Hypotheses; 2005; 65(1):194. PubMed ID: 15893141
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guideline 'Treatment of breast cancer 2008' (revision)].
    Struikmans H; Nortier JW; Rutgers EJ; Zonderland HM; Bontenbal M; Elkhuizen PH; van Tienhoven G; Tjan-Heijnen VC; van Vegchel T; Tuut MK; Benraadt J
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2507-11. PubMed ID: 19055257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy].
    Kitagawa D; Saji S
    Gan To Kagaku Ryoho; 2007 May; 34(5):690-3. PubMed ID: 17496438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 25. National Cancer Patient Registry--Breast Cancer (NCPR-Breast Cancer).
    Nor Aina E
    Med J Malaysia; 2008 Sep; 63 Suppl C():72-3. PubMed ID: 19227677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review.
    Yoshimoto M; Tada K; Hori H; Morota A; Tanabe M; Nishimura S; Takahashi K; Makita M; Iwase T; Kasumi F; Takahashi S; Ito Y; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Jpn J Clin Oncol; 2004 Aug; 34(8):457-62. PubMed ID: 15371463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
    Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations for adjuvant chemo- and hormone therapy of breast carcinoma].
    Ridwelski K; Fahlke J
    Zentralbl Chir; 1998; 123 Suppl 5():142-6. PubMed ID: 10063600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reduced breast cancer mortality. Early treatment, as endocrine and cytostatic adjuvant therapy is effective].
    Ottosson-Lönn S; Wallgren A
    Lakartidningen; 1998 Aug; 95(34):3494-7. PubMed ID: 9742830
    [No Abstract]   [Full Text] [Related]  

  • 31. Undertreatment strongly decreases prognosis of breast cancer in elderly women.
    Bouchardy C; Rapiti E; Fioretta G; Laissue P; Neyroud-Caspar I; Schäfer P; Kurtz J; Sappino AP; Vlastos G
    J Clin Oncol; 2003 Oct; 21(19):3580-7. PubMed ID: 12913099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary systemic therapy in breast cancer: past lessons and new approaches.
    Herold CI; Marcom PK
    Cancer Invest; 2008 Dec; 26(10):1052-9. PubMed ID: 19093262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breast and endocrine tumor. III].
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2228-35. PubMed ID: 18183684
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative chemotherapy and potential impact on re-excision for early breast cancer.
    Batsis H; Ignantiadou E; Harissis HV
    Ann Surg Oncol; 2009 Oct; 16(10):2956-7; author reply 2958-9. PubMed ID: 19575266
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast-conserving therapy in patients with an inherited susceptibility to breast cancer.
    Nixon AJ
    Cancer J Sci Am; 1998; 4(5):296-7. PubMed ID: 9815291
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary breast sarcoma.
    Lum YW; Jacobs L
    Surg Clin North Am; 2008 Jun; 88(3):559-70, vi. PubMed ID: 18514698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
    Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
    Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
    Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
    Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.